Table 6.
Global assessment of efficacy.∗,†
| Variables | Group, number (%) | P Value | |
|---|---|---|---|
| CCH1 (n = 39) | Lactulose (n = 34) | ||
| Marked improved | 21 (53.8) | 18 (52.9) | 0.646 |
| Slightly improved | 12 (30.8) | 9 (26.5) | |
| Unchanged | 5 (12.8) | 7 (20.6) | |
| Slightly worse | 1 (2.6) | 0 (0) | |
| Markedly worse | 0 (0) | 0 (0) | |
*The global assessment of efficacy was evaluated at the end of treatment phase by patients themselves or their principal caregivers if their cognition was impaired.
†A total of 20 patients dropped out of the trial during the treatment phase.